University of Glasgow: Revealing the Impact of Tirzepatide Treatment on Muscle Composition in Type 2 Diabetes
May 01, 2025
May 01, 2025
GLASGOW, Scotland, May 1 -- The University of Glasgow issued the following news:
* * *
Revealing the impact of tirzepatide treatment on muscle composition in type 2 diabetes
A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat infiltration in individuals with Type 2 Diabetes.
Published in The Lancet Diabetes & Endocrinology, the study is the result of a research collabo . . .
* * *
Revealing the impact of tirzepatide treatment on muscle composition in type 2 diabetes
A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat infiltration in individuals with Type 2 Diabetes.
Published in The Lancet Diabetes & Endocrinology, the study is the result of a research collabo . . .